Symptoms in patients with asthma infected by SARS-CoV-2 - 18/08/21
![](/templates/common/images/mail.png)
Abstract |
Introduction |
Organ tropism of SARS-CoV-2 to the respiratory tract could potentially aggravate asthma. The susceptibility of patients with asthma to develop an exacerbation when they are infected with SARS-CoV-2 is unknown. We aimed to investigate the symptoms presented in patients with asthma who became infected with SARS-CoV-2.
Methods and results |
All patients over 14 years of age who tested positive for SARS-CoV-2 (by RT-PCR) were included (n = 2995). In patients with asthma (n = 77, 2.6%; 44 females), symptoms, therapy and phenotype were recorded. Seventeen (22%) patients had mild asthma, 55 (71%) moderate and five severe (6%). Twenty-six patients with asthma (34%) were asymptomatic, 34 (44%) developed symptoms but did not require hospital admission, and 17 (22%) were hospitalised. One patient was admitted because of asthma exacerbation without pneumonia or other symptoms. Ten patients (13%) had wheezes (six with pneumonia). Comparison of wheezing between patients with non-T2 asthma and the rest of the patients was statistically significant, (p < 0.001).
Conclusions |
SARS-CoV-2 infection is not a significant cause of asthma exacerbation, although some patients may present wheezing, especially in cases of pneumonia. The severity of asthma does not seem to be associated with symptoms of the disease.
Le texte complet de cet article est disponible en PDF.Highlights |
• | SARS-CoV-2 is associated with wheezing in only a minority of patients with asthma. |
• | Wheezing is more frequent in patients with asthma and pneumonia due to COVID-19. |
• | Asthma exacerbation as a manifestation of COVID-19 is extremely rare. |
Keywords : Asthma, Covid-19, Virus
Plan
Vol 185
Article 106495- août 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.